A cutting-edge AI-powered mammography software is on the rise, promising not only to improve the detection of breast cancer but also to enhance the efficiency of mammography assessments. Therapixel has recently announced significant advancements to its MammoScreen suite, which has successfully received new 510(k) clearances from the FDA for evaluating breast density and launching new software designed to tackle workflow challenges faced by radiologists.
The updated MammoScreen suite is touted as a game-changer for breast cancer screening and has integrated various features aimed at streamlining the radiology process. Notably, the software includes an automated pre-reporting system that allows for quicker and more efficient reporting of mammography findings. This improvement could significantly reduce bottlenecks that are often encountered in radiology departments.
A key aspect of the upgraded suite is its ability to organize daily worklists based on a case complexity index, which enables radiologists to prioritize their cases more effectively. Furthermore, the software is equipped with advanced algorithms for assessing both 2D and 3D breast imaging, while also considering the patient’s previous medical history. These enhancements are designed to provide radiologists with a comprehensive view, facilitating timely and accurate diagnoses.
Matthieu Leclerc-Chalvet, CEO of Therapixel, states, “With these new features, radiologists can double their reading time savings compared to the previous version. Radiologists will appreciate the reduced fatigue, administrators the improved efficiency and care consistency, and the IT team the seamless one-time installation. We’re proud to launch this new version of MammoScreen, once again delivering unparalleled value to radiologists and patients.” This highlights the multifaceted benefits the updated software brings to various stakeholders involved in the healthcare process.
Overall, the new version of MammoScreen aims to not only enhance breast cancer detection rates but also to improve the workflows for radiologists, ultimately leading to better patient care. By integrating advanced technology into the mammography process, Therapixel is setting a new standard for breast cancer screening, demonstrating its commitment to innovation in healthcare.
About The Author
